Literature DB >> 21295170

Effects of long-term vitamin K(1) (phylloquinone) or vitamin K(2) (menaquinone-4) supplementation on body composition and serum parameters in rats.

Natsuko Sogabe1, Rieko Maruyama, Otto Baba, Takayuki Hosoi, Masae Goseki-Sone.   

Abstract

Vitamin K is a cofactor for γ-glutamyl carboxylase, which is an essential enzyme for the γ-carboxylation of vitamin K-dependent proteins such as osteocalcin and matrix Gla protein. Although it has been suggested that vitamin K plays an important role in the improvement of bone metabolism, the relationship between dietary vitamin K intake and bone metabolism has not been thoroughly investigated. Moreover, vitamin K is thought to have other actions beyond influencing the γ-carboxylation status. In the present study, we examined the effects of the long-term addition of phylloquinone (PK) or menaquinone-4 (MK-4) to a control diet on bone mineral density, bone strength, body composition, and serum parameters in rats. A total of 23 female Sprague-Dawley strain rats (6 weeks old) were divided into three groups: basic control diet group, PK diet (PK: 600mg/kg diet) group, and MK diet (MK-4: 600mg/kg diet) group. Three months after starting the experimental diet, the addition of PK to the basic control diet significantly increased the bone mineral density (BMD) of the femur (p<0.05). In the MK group, there was no significant difference in the BMD of the femur. However, two types of bone strength parameter: the minimum cross-sectional moment of inertia and the polar moment of inertia, were significantly higher in the MK group than in the control (p<0.05, respectively). Furthermore, the femoral bone parameters (the width, dry weight and ash weight, and cortical, cancellous, trabecular, and total bone mineral contents) in the MK group were increased significantly compared with the control. Interestingly, the addition of PK or MK-4 significantly decreased the total fat accumulation (p<0.01 and p<0.05, respectively), and serum triglycerides were reduced by 48% in the PK group and 29% in the MK group compared with the control. There were no significant differences in the levels of serum calcium, phosphorus, alkaline phosphatase, growth hormone, insulin-like growth hormone-1, insulin-like growth hormone binding protein-3, and cross-linked N-teleopeptide of type I collagen among the three groups. This is the first study to demonstrate the effect of the long-term addition of PK or MK-4 to the control diet on body composition and serum parameters in an in vivo system using rats. Further studies on the mechanism of vitamin K supplementation in the regulation of bone metabolism would provide valuable data on the prevention of lifestyle-related disorders, including osteoporosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295170     DOI: 10.1016/j.bone.2011.01.020

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

1.  The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes.

Authors:  Michael L Nickerson; Allen D Bosley; Jayne S Weiss; Brittany N Kostiha; Yoshihisa Hirota; Wolfgang Brandt; Dominic Esposito; Shigeru Kinoshita; Ludger Wessjohann; Scott G Morham; Thorkell Andresson; Howard S Kruth; Toshio Okano; Michael Dean
Journal:  Hum Mutat       Date:  2012-11-27       Impact factor: 4.878

2.  Vitamin K-induced effects on body fat and weight: results from a 3-year vitamin K2 intervention study.

Authors:  M H J Knapen; K M Jardon; C Vermeer
Journal:  Eur J Clin Nutr       Date:  2017-09-27       Impact factor: 4.016

3.  Phylloquinone Intake Is Associated with Cardiac Structure and Function in Adolescents.

Authors:  Mary K Douthit; Mary Ellen Fain; Joshua T Nguyen; Celestine F Williams; Allison H Jasti; Bernard Gutin; Norman K Pollock
Journal:  J Nutr       Date:  2017-10-01       Impact factor: 4.798

Review 4.  A critical review of the effects of vitamin K on glucose and lipid homeostasis: its potential role in the prevention and management of type 2 diabetes.

Authors:  Nikolaos A Varsamis; Georgios A Christou; Dimitrios N Kiortsis
Journal:  Hormones (Athens)       Date:  2021-01-16       Impact factor: 2.885

5.  Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study.

Authors:  Sousan Kolahi; Bahram Pourghassem Gargari; Mehran Mesgari Abbasi; Mohammad Asghari Jafarabadi; Neda Ghamarzad Shishavan
Journal:  Nutr Res Pract       Date:  2015-03-04       Impact factor: 1.926

6.  Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis.

Authors:  Naeti Suksomboon; Nalinee Poolsup; Htoo Darli Ko Ko
Journal:  Diabetes Metab Syndr Obes       Date:  2017-05-02       Impact factor: 3.168

Review 7.  Vitamin K intake and the risk of fractures: A meta-analysis.

Authors:  Guangliang Hao; Bei Zhang; Mingyong Gu; Chen Chen; Qiang Zhang; Guichun Zhang; Xuecheng Cao
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Phylloquinone and Menaquinone-4 Tissue Distribution at Different Life Stages in Male and Female Sprague-Dawley Rats Fed Different VK Levels Since Weaning or Subjected to a 40% Calorie Restriction since Adulthood.

Authors:  Guylaine Ferland; Isabelle Doucet; Dominique Mainville
Journal:  Nutrients       Date:  2016-03-04       Impact factor: 5.717

9.  Dietary intake of vitamin K in relation to bone mineral density in Korea adults: The Korea National Health and Nutrition Examination Survey (2010-2011).

Authors:  Mi-Sung Kim; Eun-Soo Kim; Cheong-Min Sohn
Journal:  J Clin Biochem Nutr       Date:  2015-10-17       Impact factor: 3.114

10.  Hexane-Isopropanolic Extract of Tungrymbai, a North-East Indian fermented soybean food prevents hepatic steatosis via regulating AMPK-mediated SREBP/FAS/ACC/HMGCR and PPARα/CPT1A/UCP2 pathways.

Authors:  Anjum Dihingia; Jijnasa Bordoloi; Prachurjya Dutta; Jatin Kalita; Prasenjit Manna
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.